Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SkyePharma and Kos sign agreement for Flutiform

May 9, 2006

Sirna and GlaxoSmithKline begin programs in asthma and RSV

May 9, 2006

Novel beta-tryptase inhibitor developed by Mochida

May 5, 2006

Recent patents impart new therapeutics for respiratory disorders

May 5, 2006

CHMP recommends Seretide dosing for initial maintenance therapy

May 5, 2006

NDA for controlled-release zileuton targeted for Q3

May 4, 2006

Pharmaxis completes end of phase II meeting for Bronchitol

May 4, 2006

Pirfenidone begins phase III CAPACITY program in IPF

May 2, 2006

Oglemilast for asthma and COPD enters phase II

May 2, 2006

CYT005-AllQbG10 shows long-term efficacy in house dust mite allergy patients

April 26, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...